Tag: risk of pml - Cupdf.com

Documents tagged

identified2 jcv exposure

Business Profesional natalizumab benefit risk update may 2013

1. TY-PAN-0597 Date of preparation: May 2013FOR HEALTHCARE PROFESSIONALS ONLYTYSABRI (natalizumab)Benefit/Risk Update &PML Risk Stratification 2. TY-PAN-0597 Date of…

Health & Medicine Tysabri safety and pml risk stratification april 2013

1. Natalizumab Safety Update &PML Risk StratificationApril 2013Gavin GiovannoniBarts and The London 2. Benefit / RiskBenefitRiskNatalizumab81% reduction inrelapse rate164%…

Business Natalizumb benefit risk update August 2013

1. TY-PAN-0597(3) Date of preparation: August 2013FOR HEALTHCARE PROFESSIONALS ONLY TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification 2. TY-PAN-0597(3)…

Health & Medicine Natalizumab safety and pml risk stratification march 2013

1. Natalizumab Safety Update & PML Risk Stratification Professor Gavin GiovannoniBarts and The LondonTY-PAN-0587(2) Date of preparation: March 2013 2. Benefit / Risk…

Business Tysabri benefit risk update july 2013 (ty-pan-0597(2))

1. TY-PAN-0597(2) Date of preparation: July 2013FOR HEALTHCARE PROFESSIONALS ONLY TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification 2. TY-PAN-0597(2)…

Health & Medicine Natalizumab PML Update June 2013

1. TY-PAN-0597(1) Date of preparation: June 2013FOR HEALTHCARE PROFESSIONALS ONLY TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification 2. TY-PAN-0597(1)…